Modulation of pain in osteoarthritis: The role of nitric oxide

Clinical Journal of Pain

Volumn 24, Issue 4, 2008, Pages 353-365

  Hancock, Celeste M ^a,b   Riegger Krugh, Cheryl ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b CRAIG HOSPITAL   (United States)

^c WALSH UNIVERSITY   (United States)

Author keywords

Inflammation; Mechanical overload; Monochromatic infrared photo energy (MIRE); Nitric oxide (NO); Osteoarthritis; Pain

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ANTINOCICEPTION; ARTICULAR CARTILAGE; CONSERVATIVE TREATMENT; DISEASE SEVERITY; GENETIC PREDISPOSITION; HUMAN; MONOCHROMATIC INFRARED PHOTOENERGY; MUSCULOSKELETAL PAIN; NEUROMODULATION; NEUROPATHOLOGY; NOCICEPTION; NOCICEPTIVE STIMULATION; OSTEOARTHRITIS; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SYNOVIOCYTE; THERAPY EFFECT; TREATMENT RESPONSE;

ANIMALS; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; OSTEOARTHRITIS; PAIN;

EID: 42449155118     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/AJP.0b013e31815e5418     Document Type: Review

References (130)

1. Creamer P. Osteoarthritis pain and its treatment. Curr Opin Rheumatol. 2000;12:450-455.
2. Dunlop DD, Manheim LM, Yelin EH, et al. The costs of arthritis. Arth Rheum. 2003;49:101-113.
3. Hosie G, Dickson J. Pharmacological treatment. In: Hosie G, Dickson J, eds. Managing Osteoarthritis in Primary Care. Malden, MA: Blackwell Science Ltd; 2000:85-97.
4. Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: relevance to osteoarthritis. Adv Drug Delivery Rev. 2006; 58:212-225.
5. Thomas G. Nitric oxide. In: Thomas G, ed. Medicinal Chemistry. New York: John Wiley & Sons Ltd; 2000:433-464.
6. Del Carlo M, Loeser R. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arth Rheum. 2002;46:394-403.
7. McAlindon TE, Cooper C, Kirwan JR, et al. Determinants of disability in osteoarthritis of the knee. Ann Rheum Dis. 1993;52: 258-262.
8. Moncada S, Higgs EA. Mechanisms of disease: the L-arginine- nitric oxide pathway. N Eng J Med. 1993;329:2002-2012.
9. Riegger-Krugh C, Burke T. Outcome in knee osteoarthritis intervention with use of the Anodyne System and Synvisc: a case study. JOSPT. 2001;31:A-38-A-39.
10. Stelian J, Gil I, Habot B, et al. Improvement of pain and disability in elderly patients with degenerative osteoarthritis of the knee treated with narrow band light therapy. J Am Geriatr Soc. 1992;40: 23-26.
11. Nolan TP, Michlovitz SL. Monochromatic infrared photo energy (MIRE). In: Nolan TP, Michlovitz SL, eds. Modalities for Therapeutic Intervention. Philadelphia, PA: F.A. Davis Co; 2005: 289-295.
12. Riegger-Krugh C, Hancock C. Unpublished Case Studies; 2003.
13. Harkless LB, DeLellis S, Carnegie DH, et al. Improved foot sensitivity and pain reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy - MIRE. J Diabetes Complications. 2006;20:81-87.
14. Radin EL, Burr DB, Caterson B, et al. Mechanical determinants of osteoarthrosis. Sem Arth Rheum. 1991;21(suppl 2):12-21.
15. Altman RD, Losada CJ. Osteoarthritis and related disorders: clinical features. In: Hockberg M, Silman AJ, Smolen JS, et al, eds. Practical Rheumatology. 3rd ed. Philadelphia: Mosby; 2004: 503-510.
16. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis, and inflammation. Rheumatology. 2005;44:7-16.
17. Martin JA, Brown TD, Heiner AD, et al. Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Rel Res. 2004; 427S:S96-S103.
18. Buckwalter JA, Mankin HJ. Articular cartilage: II. degeneration and osteoarthrosis, repair, regeneration and transplantation. J Bone Joint Surg. 1997;79A:612-632.
19. Patwari P, Fay J, Grodzinsky AJ, et al. In-vitro models for investigation of the effects of acute mechanical injury on cartilage. Clin Orthop Rel Res. 2001;391S:S61-S71.
20. Martel-Pelletier J, Di Battista J, Lajeunesse D. Biochemical factors in joint articular degradation in osteoarthritis. In: Reginster JY, Pelletier JP, Martel-Pelletier J, et al, eds. Osteoarthritis: Clinical and Experimental Aspects. New York: Springer-Verlag; 1999: 156-187.
21. Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med. 2001;134:541-549.
22. Kidd BL, Morris VH, Urban L. Pathophysiology of joint pain. Ann Rheum Dis. 1996;55:276-283.
23. Dhesi SS, Hurley RW. The neurobiology of pain. In: Tollison CD, Satterthwaite JR, Tollison JW, eds. Practical Pain Management. 3rd ed. Philadelphia: Lippincott Williams, & Wilkins; 2002:10-25.
24. Cohen M. Principles of pain and pain management. In: Hockberg M, Silman AJ, Smolen JS, et al, eds. Practical Rheumatology. 3rd ed. Philadelphia: Mosby; 2004:105-111.
25. Dieppe P. Subchondral bone should be the main target for the treatment of pain and disease progression in osteoarthritis. Osteoarthritis Cartilage. 1999;7:325-326.
26. Uchio Y, Ochi M, Adachi N, et al. Intraosseous hypertension and venous congestion in osteonecrosis of the knee. Clin Orthop. 2001; 384:217-223.
27. Chang A, Hayes K, Dunlop D, et al. Hip abduction moment and protection against medial tibiofemoral osteoarthritis progression. Arth Rheum. 2005;52:3515-3519.
28. Chang A, Hayes K, Dunlop D, et al. Thrust during ambulation and the progression of knee osteoarthritis. Arth Rheum. 2004;50: 3897-3903.
29. Felson DT. Risk factors for osteoarthritis: understanding joint vulnerability. Clin Orthop Rel Res. 2004;427 suppl:S16-S21.
30. Sharma L, Cahue S, Song J, et al. Physical functioning over three years in knee osteoarthritis: role of psychosocial, local mechanical, and neuromuscular factors. Arth Rheum. 2003;48:3359-3370.
31. Sharma L, Song J, Felson DT, et al. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA. 2001;286:188-196.
32. Sharma L. Examination of exercise effects on knee OA outcomes: why should the local mechanical environment be considered. Arth Rheum. 2003;49:255-260.
33. Sharma L, Hayes KW, Felson DT, et al. Does laxity alter the relationship between strength and physical function in knee osteoarthritis? Arth Rheum. 1999;41:25-32.
34. Riegger-Krugh C, Keysor JJ. Skeletal malalignments of the lower quarter: correlated and compensatory motions and postures. JOSPT. 1996;23:164-169.
35. Felson DT, Goggins J, Niu J, et al. The effect of body weight on progression of knee osteoarthritis is dependent on alignment. Arth Rheum. 2004;50:3904-3909.
36. Lievense AM, Bierma-Zeinstra SM, Verhagen AP, et al. Influence of obesity on the development of osteoarthritis of the hip: a systematic review. Rheumatology. 2002;41:1155-1162.
37. Radin EL, Yang KH, Riegger C, et al. Relationship between lower limb dynamics and knee joint pain. J Orthop Res. 1991;9: 398-405.
38. Losada CJ, Altman RD. Management of limb joint osteoarthritis. In: Hockberg MC, Silman AJ, Smolen JS, et al. eds. Practical Rheumatology. 3rd ed. Philadelphia: Mosby; 2004:511-519.
39. Slemender C, Brandt KD, Heilman MS, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med. 1997;127:97-104.
40. Moskowitz RW, Howell DS, Goldberg VM, et al. Osteoarthritis: Diagnosis and Management. Philadelphia: WB Saunders; 1984: 149-154; 403-408.
41. Nurmikko TJ, Nash TP, Wiles JR. Control of chronic pain. BMJ. 1998;317:1438-1441.
42. Macera CA. Major public health benefits of physical activity. Arth Care Res. 2003;49:122-129.
43. Hootman J. Physical activity levels among the general US adult population and in adults with and without arthritis. Arth Care Res. 2003;49:129-136.
44. Eyler A. Correlates of physical activity: who's active and who's not. Arth Care Res. 2003;49:136-141.
45. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2000;59: 936-944.
46. Hurley M, Walsh N. Physical, functional, and other nonpharmacological interventions for osteoarthritis. Best Pract Res Clin Rheumatol. 2001;15:569-582.
47. Welch V, Brosseau L, Shea B, et al. Thermotherapy for treating rheumatoid arthritis. [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 4, 2000.
48. Mazzuca SA, Page MC, Meldrum RD, et al. Pilot study of the effects of a heat-retaining knee sleeve on joint pain, stiffness, and function in patients with knee osteoarthritis. Arth Rheum. 2004; 51:716-721.
49. Brosseau L, Judd MG, Marchand S, et al. Thermotherapy for treatment of osteoarthritis [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2005.
50. Robinson L, Brosseau L, Peterson J, et al. Therapeutic ultrasound for osteoarthritis of the knee [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2005.
51. van der Windt DA, van der Heijden GJ, van den Berg SG, et al. Ultrasound therapy for musculoskeletal disorders: a systematic review. Pain. 1999;81:257-271.
52. Gam AN, Johannsen F. Ultrasound therapy in musculoskeletal disorders: a meta-analysis. Pain. 1995;63:85-91.
53. Brosseau L, Gam A, Harman K, et al. Low level laser therapy (Classes I, II and III) for treating osteoarthritis [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2005.
54. Beckerman H, de Bie RA, Bouter LM, et al. The efficacy of laser therapy for musculoskeletal and skin disorders: a criteria-based meta-analysis of randomized clinical trials. Phys Ther. 1992;72: 483-491.
55. deBie R, Verhagen AP. Efficacy of 904nm laser therapy in the management of musculoskeletal disorders: a systematic review. Phys Ther Rev. 1998;3:59-72.
56. Osiri M, Brosseau L, McGowan J, et al. Transcutaneous electrical nerve stimulation for knee osteoarthritis [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2005.
57. Cheing GL, Tsui AY, Lo SK, et al. Optimal stimulation duration of tens in the management of osteoarthritic knee pain. J Rehabil Med. 2003;35:62-68.
58. Hulme J, Judd M, Tugwell P. Electromagnetic fields for the treatment of osteoarthritis [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2002.
59. Trock DH, Bollet AJ, Markoll R. The effect of pulsed electromagnetic fields in the treatment of osteoarthritis of the knee and cervical spine. Report of randomized, double blind, placebo controlled trials. J Rheum. 1994;21:1903-1911.
60. Trock DH, Bollet AJ, Dyer RH, et al. A double-blind trial of the clinical effects of pulsed electromagnetic fields in osteoarthritis. J Rheumatol. 1993;20:456-460.
61. Zizic TM, Hoffman KC, Holt PA, et al. The treatment of osteoarthritis of the knee with pulsed electrical stimulation. J Rheumatol. 1995;22:1757-1761.
62. Deyle GD, Henderson NE, Matekel RL, et al. Effectiveness of manual therapy and exercise in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med. 2000;132:173-181.
63. Hoeksma HL, Dekker J, Ronday HK, et al. Comparison of manual therapy and exercise therapy in osteoarthritis of the hip: a randomized clinical trial. Arth Rheum. 2004;1:722-729.
64. Hoeksma HL, Van Den Ende CH, Ronday HK, et al. Comparison of the responsiveness of the Harris Hip Score with generic measures for hip function in osteoarthritis of the hip. Ann Rheum Dis. 2003;62:935-938.
65. Fitzgerald GK, Oatis C. Role of physical therapy in management of knee osteoarthritis. Curr Opinion Rheumatol. 2004;16:143-147.
66. Philadelphia Panel. Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain. Meta-Analysis. Practice Guideline. Phys Ther. 2001;81: 1675-1700.
67. Verhagen AP, de Vet HC, de Bie RA, et al. Taking baths: the efficacy of balneotherapy in patients with arthritis. A systematic review. J Rheumatol. 1997;24:1964-1971.
68. Foley A, Halbert J, Hewitt T, et al. Does hydrotherapy improve strength and physical function in patients with osteoarthritis - a randomised controlled trial comparing a gym based and a hydrotherapy based strengthening programme. Ann Rheum Dis. 2003;62:1162-1167.
69. Patrick DL, Ramsey SD, Spencer AC, et al. Economic evaluation of aquatic exercise for persons with osteoarthritis. Med Care. 2001;39:413-424.
70. Guillemin F, Virion JM, Escudier P, et al. Effects on osteoarthritis of spatherapy at Bourbonne-les-Bains. Joint Bone Spine. 2001;68: 499-503.
71. Green J, McKenna F, Redfern EJ, et al. Home exercises are as effective as outpatient hydrotherapy for osteoarthritis of the hip. Br J Rheumatol. 1993;32:812-815.
72. Nguyen M, Revel M, Dougados M. Prologed effects of 3 weeks therapy in a Spa resort on lumbar spine, knee and hip osteoarthrosis: follow-up after 6 months. A randomized controlled trial. Br J Rheumatol. 1997;36:77-91.
73. Fransen M, McConnell S, Bell M. Exercise for osteoarthritis of the hip or knee [Systematic Review] Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2000.
74. van Baar ME, Assendelft WJ, Dekker J, et al. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arth Rheum. 1999; 42:1361-1369.
75. van Baar ME, Dekker J, Oostendrorp RA, et al. Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months follow up. Ann Rheum Dis. 2001;60:1123-1130.
76. Minor MA, Sanford MK. Physical interventions in the management of pain in arthritis. Arth Care Res. 1993;6:197-206.
77. Hurley MV. Muscle Dysfunction and effective rehabilitation of knee osteoarthritis: what we know and what we need to find out. Arth Rheum. 2003;49:444-452.
78. Brosseau L, MacLeay L, Robinson V, et al. Intensity of exercise for the treatment of osteoarthritis. Cochrane Database of Systematic Reviews. 2, 2003.
79. Westby MD. A health professional's guide to exercise prescription for people with arthritis: a review of aerobic fitness activities. Arth Rheum. 2001;45:501-511.
80. Warsi A, LaValley MP, Wang PS, et al. Arthritis self-management education programs: a meta-analysis of the effect on pain and disability. Arth Rheum. 2003;48:2207-2213.
81. Riemsma RP, Kirwan JR, Taal E, et al. Patient education for osteoarthritis [Protocol]. Cochrane Musculoskeletal Group: Cochrane Database of Systematic Reviews. 1, 2006.
82. Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a metaanalytic comparison with nonsteroidal antiinflammatory drug treatment. Arth Care Res. 1996;9:292-301.
83. Messier SP, Loeser RF, Mitchell MN, et al. Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study. J Am Geriatr Soc. 2000;48:1062-1072.
84. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Int Med. 1992;116:535-539.
85. Brouwer RW, Jakma TSC, Verhagen AP, et al. Braces and orthoses for treating osteoarthritis of the knee [Systematic Review] Cochrane Musculoskeletal Group. Cochrane Database of Systematic Reviews. 1, 2005.
86. Toda Y, Segal N, Kato A, et al. Effect of a novel insole on the subtalar joint of patients with medial compartment osteoarthritis of the knee. J Rheumatol. 2001;28:2705-2710.
87. Matsuno H, Kadowaki KM, Tsuji H. Generation II knee bracing for severe medial compartment osteoarthritis of the knee. Arch Phys Med Rehabil. 1997;78:745-749.
88. Krebs DE, Robbins CE, Lavine L, et al. Hip biomechanics during gait. J Orthop Sports Phys Ther. 1998;28:51-59.
89. Tackson SJ, Krebs DE, Harris BA. Acetabular pressures during hip arthritis exercises. Arth Care Res. 1997;10:308-319.
90. Hosie G, Dickson J. Management options - education, behavioral and environmental. In: Hosie G, Dickson J, eds. Managing Osteoarthritis in Primary Care. Malden, MA: Blackwell Science Ltd; 2000:66-77.
91. Voloshin AS, Mizrahi J, Verbitsky O, et al. Dynamic loading on the human musculoskeletal system - effect of fatigue. Clin Biomech (Bristol, Avon). 1998;13:515-520.
92. Voloshin A. The influence of walking speed on dynamic loading on the human musculoskeletal system. Med Sci Sports Exerc. 2000;32:1156-1159.
93. McGibbon CA, Krebs DE, Trahan CA, et al. Cartilage degeneration in relation to repetitive pressure: case study of a unilateral hip hemiarthroplasty patient. J Arthroplasty. 1999;14:52-58.
94. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arth Rheum. 2001;44:1237-1247.
95. Evans CH, Stefanovic-Racic M, Lancaster J. Nitric oxide and its role in orthopedic disease. Clin Orthop Rel Res. 1995;312:275-294.
96. Luo ZD, Cizkova D. The role of nitric oxide in nociception. Curr Rev Pain. 2000;4:459-466.
97. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995;9:1319-1330.
98. Amin AR, DiCesare PE, Vyas P, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med. 1995;182:2097-2102.
99. Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23(6 Pt 2):1121-1131.
100. Blake DR, Bodamyali T, Stevens CR, et al. Free radicals and pathology: current concepts. In: Winyard PG, Blake DR, Evans CH, eds. Free Radicals and Inflammation. Basel, Switzerland: Birkhauser Verlag; 2000:17-19.
101. Tomita M, Sato EF, Nishikawa M, et al. Nitric oxide regulates mitochondrial respiration and functions of articular chondrocytes. Arth Rheum. 2001;44:96-104.
102. Silverstein RL. The vascular endothelium. In: Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Correlates. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 1999:207-225.
103. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Res. 1991;43: 109-142.
104. Van den Berg WB, van der Kraan PM, van Beuningen HM. Role of growth factors and cartilage repair. In: Reginster JY, Pelletier JP, Martel-Pelletier J, et al. eds. Osteoarthritis: Clinical and Experimental Aspects. New York: Springer-Verlag; 1999:188-205.
105. Lockhart JC, McMurdo L, Ferrell WR. Nitric oxide and blood flow in arthritis. In: Hukkanen MVJ, Polak JM, Hughes SPF, eds. Nitric Oxide in Bone and Joint Disease. Cambridge, UK: Cambridge University Press; 1998:41-50.
106. Ghosh P. Pathophysiology of OA: role of biomechanical factors. In: Reginster JY, Pelletier JP, Martel-Pelletier J, et al, eds. Osteoarthritis: Clinical and Experimental Aspects. New York: Springer-Verlag; 1999:115-133.
107. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am. 1999;25:269-282.
108. McCarthy ID. Modulation of bone blood flow by nitric oxide. In: Hukkanen MVJ, Polak JM, Hughes SPF, eds. Nitric Oxide in Bone and Joint Disease. Cambridge, UK: Cambridge University Press; 1998:129-140.
109. Fox SW, Chambers TJ, Chow JWM. Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol. 1996;270(Endocrinol Metabol 33): E955-E960.
110. Pitsillides AA, Lanyon LE. Mechanical strain-associated nitric oxide production by bone cells. In: Hukkanen MVJ, Polak JM, Hughes SPF, eds. Nitric Oxide in Bone and Joint Disease. Cambridge, UK: Cambridge University Press; 1998:151-164.
111. Collin-Osdoby P, Nickols GA, Osdoby P. Bone cell function, regulation, and communication: a role for nitric oxide. J Cell Biochem. 1995;57:399-408.
112. Vasa M, Breitschopt K, Zeiher AM, et al. Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res. 2000; 87:540-542.
113. Haywood L, McWilliams DF, Pearson CI, et al. Inflammation and angiogenesis in osteoarthritis. Arth Rheum. 2003;48:2173-2177.
114. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413:203-210.
115. Jackson JR, Minton JA, Ho MI, et al. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1-beta. J Rheumatol. 1997;24:1253-1259.
116. Stockhert BW, Kenny L, Edgelow PI. Beyond the central nervous system: neurovascular entrapment syndromes. In: Umphred D, ed. Neurological Rehabilitation. 4th ed. St Louis: Mosby; 2001:351-362.
117. Martin JA, Brown TD, Heiner AD, et al. Chondrocyte senescence, joint loading, and osteoarthritis. Clin Orthop. 2004;427(suppl): S96-S103.
118. DeGroot J, Verzijl N, Marion JG, et al. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arth Rheum. 2004;50:1207-1215.
119. Duarte IDG, Ferreira SH. The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. Eur J Pharmacol. 1992;221:171-174.
120. Duarte IDG, dos Santos IR, Lorenzetti BB, et al. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur J Pharmacol. 1992;217:225-227.
121. Ferreira SH, Duarte IDG, Lorenzetti BB. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol. 1991;201:121-122.
122. Jackson KC II, Lipman AG. Opioid analgesics. In: Tollison CD, Satterthwaite JR, Tollison JW, eds. Practical Pain Management. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2002: 216-230.
123. Puehler W, Stein C. Controlling pain by influencing neurogenic pathways. Rheum Dis Clin North Am. 2005;31:103-113.
124. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg. 1993;76:182-191.
125. Ferreira SH, Duarte IDG, Lorenzetti BB. Molecular base of acetylcholine and morphine analgesia. Agents Actions Suppl. 1991; 32:101-106.
126. Cabot PJ, Carter K, Gaiddon C, et al. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Investig. 1997;100:142-148.
127. Cabot PJ, Carter L, Schafer M, et al. Methionine-enkephalin- and dynorphin A-release from immune cells and control of inflammatory pain. Pain. 2001;93:207-212.
128. Stein C, Comisel K, Haimerl E, et al. Analgesic effect of intra-articular morphine after arthroscopic knee surgery. N Engl J Med. 1991;325:1123-1126.
129. Burke T. Nitric oxide and its role in health and diabetes. Diabetes in Control.com Newsletter, 2002; Issue 76, Part 4.
130. Maegawa Y, Itoh T, Hosokawa T, et al. Effects of near-infrared low-level laser irradiation on microcirculation. Lasers Surg Med. 2000;27:427-437.